Sorrento Therapeutics In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies from Mabtech Limited
August 03, 2015 at 06:04 AM EDT
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced today that it has entered into an exclusive licensing agreement to develop and ...
